NCT02906618View on ClinicalTrials.gov

Study of LY3039478 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 4, 2016

Primary Completion Date

November 11, 2016

Study Completion Date

November 11, 2016

Conditions
Healthy
Interventions
DRUG

LY3039478

Administered orally

DRUG

13C 15N 2H-LY3039478 IV

Administered IV

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Leeds

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02906618 - Study of LY3039478 in Healthy Participants | Biotech Hunter | Biotech Hunter